2,4-Dibromo-6-[[[[(4S,5S)-4,5-dihydro-4,5-diphenyl-1-tosyl-1H-imidazol-2-yl]methyl][(S)-1-phenylethyl]amino]methyl]phenol
CAS : 1009582-56-2
Ref. 3D-FD59986
10mg | Arrêté | ||
25mg | Arrêté | ||
50mg | Arrêté | ||
100mg | Arrêté | ||
250mg | Arrêté |
Informations sur le produit
- IAP
2,4-Dibromo-6-[[[[(4S,5S)-4,5-dihydro-4,5-diphenyl-1-tosyl-1H-imidazol-2-yl]methyl][(S)-1-phenylethyl]amino]methyl]phenol (ZD1839) is a potent apoptosis inducer that inhibits tumor necrosis factor alpha (TNFα) production by binding to the tnf receptor. ZD1839 also induces caspase independent cell death and has been shown to be effective in treating pancreatitis and subcutaneous tumors. This drug has been shown to inhibit the expression of survivin, an important protein for tumor cell survival.